Literature DB >> 20599567

A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage.

Luigi Carlessi1, Giacomo Buscemi, Enrico Fontanella, Domenico Delia.   

Abstract

The checkpoint kinase Chk2 is an effector component of the ATM-dependent DNA damage response (DDR) pathway. The activation of Chk2 by genotoxic stress involves its phosphorylation on T68 by ATM and additional auto/transphosphorylations. Here we demonstrate that in unperturbed cells, chemical inhibition of Chk2 by VRX0466617 (VRX) enhances the phosphorylation of Chk2-T68 throughout the cell cycle phases. This event, dependent on the presence of ATM and catalytically functional Chk2, is not consequential to DNA damage, as neither gamma-H2AX nuclear foci nor increased ATM activation is detected in VRX-treated cells, suggesting the involvement of other regulatory proteins. As serine/threonine protein phosphatases (PPs) regulate the phosphorylation and deactivation of proteins of the DDR pathway, we analyzed their role in phospho-T68-Chk2 regulation. We found that intracellular inhibition of PP1 and PP2A-like activities by okadaic acid markedly raised the accumulation of Chk2-pT68 without DNA damage induction, and this phenomenon was also seen when PP1-C, PP2A-C, and Wip1/PPM1D were simultaneously knockdown by siRNA. Altogether, these data indicate a novel mechanism in undamaged cells where PPs function to maintain the balance between ATM and its direct substrate Chk2 through a regulatory circuit.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599567     DOI: 10.1016/j.bbamcr.2010.06.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

2.  Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts.

Authors:  Jean Y J Wang; Christian Gespach; Olivier DE Wever; Joëlle Sobczak-Thépot; Anne-Sophie Vercoutter-Edouart; Jean-Claude Michalski; Radia Ouelaa-Benslama; Dwayne G Stupack; Marc Bracke; Shahin Emami
Journal:  Int J Oncol       Date:  2011-05-09       Impact factor: 5.650

Review 3.  DNA repair targeted therapy: The past or future of cancer treatment?

Authors:  Navnath S Gavande; Pamela S VanderVere-Carozza; Hilary D Hinshaw; Shadia I Jalal; Catherine R Sears; Katherine S Pawelczak; John J Turchi
Journal:  Pharmacol Ther       Date:  2016-02-16       Impact factor: 12.310

4.  The protein phosphatase 2A inhibitor LB100 sensitizes ovarian carcinoma cells to cisplatin-mediated cytotoxicity.

Authors:  Ki-Eun Chang; Bih-Rong Wei; James P Madigan; Matthew D Hall; R Mark Simpson; Zhengping Zhuang; Michael M Gottesman
Journal:  Mol Cancer Ther       Date:  2014-11-05       Impact factor: 6.261

5.  Wild-type p53-induced phosphatase 1 (Wip1) forestalls cellular premature senescence at physiological oxygen levels by regulating DNA damage response signaling during DNA replication.

Authors:  Hiroyasu Sakai; Hidetsugu Fujigaki; Sharlyn J Mazur; Ettore Appella
Journal:  Cell Cycle       Date:  2014-01-31       Impact factor: 4.534

6.  Checkpoint kinase 2 is required for efficient immunoglobulin diversification.

Authors:  Kathrin Davari; Samantha Frankenberger; Angelika Schmidt; Nils-Sebastian Tomi; Berit Jungnickel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

7.  Elevated cyclin G2 expression intersects with DNA damage checkpoint signaling and is required for a potent G2/M checkpoint arrest response to doxorubicin.

Authors:  Maike Zimmermann; Aruni S Arachchige-Don; Michaela S Donaldson; Robert F Dallapiazza; Colleen E Cowan; Mary C Horne
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

Review 8.  Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum.

Authors:  Ahmed Y Ali; Lee Farrand; Ji Young Kim; Sanguine Byun; Jeong-Yong Suh; Hyong Joo Lee; Benjamin K Tsang
Journal:  Ann N Y Acad Sci       Date:  2012-10       Impact factor: 5.691

Review 9.  CHK2 kinase in the DNA damage response and beyond.

Authors:  Laura Zannini; Domenico Delia; Giacomo Buscemi
Journal:  J Mol Cell Biol       Date:  2014-11-17       Impact factor: 6.216

10.  Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers.

Authors:  Laura B Kleiman; Angela M Krebs; Stephen Y Kim; Theodore S Hong; Kevin M Haigis
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.